First Analysis provided the funding for the Ascension Health and Legacy Life Science-backed orthopaedic device maker as it prepares to release its next product.
Sonoma Orthopedic Products, a US-based, corporate-backed orthopaedic device producer, has raised $12m from growth equity firm First Analysis to support the launch and commercialisation of its new ankle implant product.
The company has now raised just over $60m since it was founded in 2005, including $22m from its last round, a 2011 series D led by Ascension Health Ventures, the corporate venturing unit of healthcare system Ascension Health.
Other past investors in Sonoma include medical device maker Legacy Life Science,…
